Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is characterized by thickening of the ventricular muscle without dilation and is often associated with dominant pathogenic variants in cardiac sarcomeric protein genes. Here, we report a family with two infants diagnosed with infantile-onset HCM and mitral valve dys...
Main Authors: | Sathiya N Manivannan, Sihem Darouich, Aida Masmoudi, David Gordon, Gloria Zender, Zhe Han, Sara Fitzgerald-Butt, Peter White, Kim L McBride, Maher Kharrat, Vidu Garg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-05-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1008639 |
Similar Items
-
Hypertrophic Cardiomyopathy
by: Asra K. Butt, et al.
Published: (2023-03-01) -
Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01) -
Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
by: Yilu Wang, et al.
Published: (2013-01-01) -
A Multi-Omics Approach Using a Mouse Model of Cardiac Malformations for Prioritization of Human Congenital Heart Disease Contributing Genes
by: Adrianna Matos-Nieves, et al.
Published: (2021-08-01) -
Hypertrophic cardiomyopathy
by: Sarita Gore, et al.
Published: (2022-01-01)